IMFINZI
Active substance: durvalumab
INJECTION, SOLUTION · DURVALUMAB 120 mg/2.4mL
United StatesActive
Marketing holder: AstraZeneca Pharmaceuticals LP
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- DURVALUMAB · 120 mg/2.4mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-fc2e-7839-a3a6-9cc29356c654,01a1208f-8210-78a7-8f0a-5f40726d9a3c,01a12099-10fc-7aac-8bf8-16a7468653c9,01a1209b-8af4-73e1-b247-c04a10d26d07;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0310-4500
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0310-4500 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0310-4500 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0310-4500 · Verified 2026-10-09 · open in source